| Test Code | 8100 |
| Turnaround Time (TAT) | 5-14 days |
| Number of Genes | 3 |
for all blood relatives of patients who undergo full single gene sequencing or multigene panel testing* at Ambry Genetics and are found to have a pathogenic or likely pathogenic variant. No-cost testing of blood relatives must be completed within 90 days of the original Ambry report date.
Order Now*excludes Secondary Findings and SNP Array tests
Clinical sensitivity for these genes is not well defined. Ambry's surfactant dysfunction testing can detect >99.9% of described mutations in the included genes, when present (analytic sensitivity).
Our Surfactant Dysfunction panel includes Sanger Sequencing of ABCA3, SFTPB, and SFTPC. Genomic deoxyribonucleic acid (gDNA) is isolated from the patient’s specimen using standardized methodology and quantified. All the analyzed regions of the gene are amplified through polymerase chain reaction (PCR) and sequence alterations are identified by double-stranded sequencing from sense and anti-sense directions. This test targets detection of DNA sequence mutations in all coding domains, and well into the 5’ and 3’ ends of all the introns and untranslated regions.